AMGEN INC (AMGN) vs VERTEX PHARMACEUTICALS INC / MA (VRTX)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | AMGN | VRTX |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $36.75B | $12B |
| Revenue growth (YoY) | ▲ 10.0% | ▲ 8.9% |
| Net income | $7.71B | $3.95B |
| Gross margin | 67.2% | 86.2% |
| Diluted EPS | $14.23 | $15.32 |
| Insider net (6 mo) | +15.3K sh • 5 sells • 0 buys | +809 sh • 14 sells • 0 buys |
| Institutional owners | 46 | 47 |
| Institutional value held | $113.58B | $86.39B |
| Next earnings (est.) | Nov 3, 2026 | Nov 2, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About AMGEN INC (AMGN)
Amgen Inc. is a global biotechnology company, incorporated in California in 1980 and reincorporated in Delaware in 1987, that discovers, develops, manufactures, and delivers innovative medicines targeting areas of high unmet medical need, operating as a… Read more →
About VERTEX PHARMACEUTICALS INC / MA (VRTX)
Vertex Pharmaceuticals is a global biotechnology company focused on discovering and developing transformative medicines for people with serious diseases, concentrating on specialty markets. Read more →
Source: SEC EDGAR.